Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
Circular RNA
Diagnosis
Human papilloma viruses
Signal transduction
Therapeutics
Uterine cervical neoplasms
Journal
Cell communication and signaling : CCS
ISSN: 1478-811X
Titre abrégé: Cell Commun Signal
Pays: England
ID NLM: 101170464
Informations de publication
Date de publication:
10 02 2024
10 02 2024
Historique:
received:
30
09
2023
accepted:
20
01
2024
medline:
11
2
2024
pubmed:
11
2
2024
entrez:
10
2
2024
Statut:
epublish
Résumé
Cervical cancer (CC) is a common gynecologic malignancy, accounting for a significant proportion of women death worldwide. Human papillomavirus (HPV) infection is one of the major etiological causes leading to CC onset; however, genetic, and epigenetic factors are also responsible for disease expansion. Circular RNAs (circRNAs), which are known as a particular subset of non-coding RNA (ncRNA) superfamily, with covalently closed loop structures, have been reported to be involved in the progression of diverse diseases, especially neoplasms. In this framework, abnormally expressed circRNAs are in strong correlation with CC pathogenesis through regulating substantial signaling pathways. Also, these RNA molecules can be considered as promising biomarkers and therapeutic targets for CC diagnosis/prognosis and treatment, respectively. Herein, we first review key molecular mechanisms, including Wnt/β-catenin, MAPK, and PI3K/Akt/mTOR signaling pathways, as well as angiogenesis and metastasis, by which circRNAs interfere with CC development. Then, diagnostic, prognostic, and therapeutic potentials of these ncRNA molecules will be highlighted in depth.
Identifiants
pubmed: 38341592
doi: 10.1186/s12964-024-01494-0
pii: 10.1186/s12964-024-01494-0
pmc: PMC10859032
doi:
Substances chimiques
RNA, Circular
0
Phosphatidylinositol 3-Kinases
EC 2.7.1.-
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
107Informations de copyright
© 2024. The Author(s).
Références
Drug Des Devel Ther. 2016 Jun 07;10:1885-95
pubmed: 27354763
Front Genet. 2020 Sep 30;11:577948
pubmed: 33193697
J Natl Cancer Inst. 2011 Mar 2;103(5):368-83
pubmed: 21282563
Semin Cancer Biol. 2021 Oct;75:49-61
pubmed: 33035655
J Cell Physiol. 2020 Feb;235(2):1287-1295
pubmed: 31256433
Cells. 2019 Jun 21;8(6):
pubmed: 31234354
J Med Virol. 2023 Jul;95(7):e28950
pubmed: 37465863
J Cancer. 2020 Oct 17;11(23):7009-7022
pubmed: 33123291
Tumour Biol. 2016 Mar;37(3):2779-88
pubmed: 26715267
Trends Cancer. 2020 Apr;6(4):319-336
pubmed: 32209446
BMC Cancer. 2018 Jun 27;18(1):696
pubmed: 29945565
Gene. 2020 Jul 15;747:144661
pubmed: 32275999
J Exp Clin Cancer Res. 2022 Aug 26;41(1):261
pubmed: 36028854
Oncol Lett. 2020 Jan;19(1):406-414
pubmed: 31897153
Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166512
pubmed: 35931405
Mol Cell. 2014 Oct 2;56(1):55-66
pubmed: 25242144
Nat Struct Mol Biol. 2015 Mar;22(3):256-64
pubmed: 25664725
Curr Med Chem. 2024 Jan 22;:
pubmed: 38258785
Cell Biochem Funct. 2022 Apr;40(3):232-247
pubmed: 35258097
Chin J Cancer Res. 2020 Dec 31;32(6):720-728
pubmed: 33446995
Int J Biol Macromol. 2022 May 1;206:939-953
pubmed: 35318084
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8771-8778
pubmed: 31696463
Gynecol Oncol. 2013 Mar;128(3):442-8
pubmed: 23168175
RNA. 2015 Feb;21(2):172-9
pubmed: 25449546
Cancer Lett. 2020 Oct 10;490:54-65
pubmed: 32682951
Gene. 2020 Apr 5;733:144273
pubmed: 31809842
J Natl Med Assoc. 2020 Apr;112(2):229-232
pubmed: 32278478
Cancer Cell Int. 2020 Jul 31;20:357
pubmed: 32760224
Biotechnol Appl Biochem. 2022 Aug;69(4):1633-1645
pubmed: 34342377
Cell Physiol Biochem. 2018;48(1):173-184
pubmed: 30007986
Brief Bioinform. 2019 Jul 19;20(4):1420-1433
pubmed: 29415187
Cancer. 2013 Nov 1;119(21):3776-83
pubmed: 24037752
Front Oncol. 2023 Jul 21;13:1224138
pubmed: 37546393
Oncogenesis. 2021 Sep 10;10(9):60
pubmed: 34508066
Mol Cell. 2017 Apr 6;66(1):22-37.e9
pubmed: 28344082
Updates Surg. 2017 Dec;69(4):441-449
pubmed: 28918603
Biochim Biophys Acta Gene Regul Mech. 2020 Jun;1863(6):194417
pubmed: 31493559
J Cell Commun Signal. 2023 Sep;17(3):627-638
pubmed: 36357650
Int J Mol Sci. 2018 Jun 08;19(6):
pubmed: 29890655
PLoS One. 2009;4(4):e5137
pubmed: 19340305
Mol Biol Rep. 2022 Mar;49(3):2421-2432
pubmed: 34850336
Onco Targets Ther. 2020 Aug 12;13:8037-8047
pubmed: 32884290
Curr Probl Cancer. 2018 Mar - Apr;42(2):120-128
pubmed: 29530393
Biomed Pharmacother. 2019 Oct;118:109311
pubmed: 31545253
Reprod Biol. 2022 Jun;22(2):100648
pubmed: 35533615
Cell Death Dis. 2020 May 26;11(5):399
pubmed: 32457332
J Cell Physiol. 2022 Apr;237(4):2095-2106
pubmed: 35128660
Nat Rev Genet. 2009 Mar;10(3):155-9
pubmed: 19188922
Eur Rev Med Pharmacol Sci. 2018 Apr;22(7):1891-1898
pubmed: 29687840
CNS Neurol Disord Drug Targets. 2022 Aug 29;:
pubmed: 36043720
Curr Oncol. 2022 Jul 05;29(7):4689-4702
pubmed: 35877232
Cell Rep. 2015 Jan 6;10(1):103-11
pubmed: 25543144
Cancers (Basel). 2018 Jun 22;10(7):
pubmed: 29932446
Eur J Pharmacol. 2023 Jul 5;950:175755
pubmed: 37119959
Cell. 2014 Sep 25;159(1):134-147
pubmed: 25242744
Reprod Sci. 2022 Jun;29(6):1822-1835
pubmed: 35023052
Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5207-E5215
pubmed: 28611215
Cell Death Dis. 2021 May 11;12(5):468
pubmed: 33976116
Nat Rev Rheumatol. 2021 Nov;17(11):692-705
pubmed: 34588660
Mol Ther Oncolytics. 2019 May 17;14:121-129
pubmed: 31194163
Int Rev Immunol. 2021;40(5):359-378
pubmed: 32853049
Int J Mol Sci. 2022 Jun 24;23(13):
pubmed: 35806027
Front Oncol. 2022 Mar 07;12:858598
pubmed: 35321435
Reprod Sci. 2020 Jan;27(1):132-144
pubmed: 32046405
Onco Targets Ther. 2019 Nov 20;12:9957-9964
pubmed: 31819492
Front Mol Neurosci. 2017 Dec 12;10:412
pubmed: 29311805
Int J Clin Exp Pathol. 2015 Oct 01;8(10):12802-10
pubmed: 26722470
Mol Cancer. 2015 Apr 17;14:87
pubmed: 26022660
J Transl Med. 2014 Sep 16;12:255
pubmed: 25220666
Mol Cancer. 2011 Nov 11;10:140
pubmed: 22078316
Cell Mol Neurobiol. 2023 Oct;43(7):3277-3299
pubmed: 37414973
Ann Med. 2016;48(3):149-61
pubmed: 26911282
Cancer Radiother. 2022 Feb-Apr;26(1-2):298-308
pubmed: 34955418
Cell Commun Signal. 2022 Jan 28;20(1):13
pubmed: 35090496
Bioengineered. 2022 Mar;13(3):5251-5261
pubmed: 35166172
Front Pharmacol. 2023 Apr 19;14:1152672
pubmed: 37153758
Int J Biol Macromol. 2023 Jan 15;225:1038-1048
pubmed: 36410538
Front Genet. 2021 Dec 17;12:779195
pubmed: 34976014
RNA. 2015 Sep;21(9):1554-65
pubmed: 26194134
Trends Cell Biol. 2020 Mar;30(3):226-240
pubmed: 31973951
Curr Mol Pharmacol. 2022;15(5):716-735
pubmed: 34923951
Int J Mol Sci. 2020 Dec 21;21(24):
pubmed: 33371204
EMBO J. 2013 Apr 3;32(7):923-5
pubmed: 23463100
Front Oncol. 2020 Feb 20;10:150
pubmed: 32154165
Cancer Biother Radiopharm. 2021 Feb;36(1):58-69
pubmed: 32119786
Methods Mol Biol. 2022;2392:103-114
pubmed: 34773618
Cancer Manag Res. 2021 Jun 01;13:4309-4315
pubmed: 34103986
Mol Cancer. 2019 Jan 9;18(1):6
pubmed: 30626395
Lancet Oncol. 2005 May;6(5):322-7
pubmed: 15863380
Am J Physiol Cell Physiol. 2019 Jul 1;317(1):C1-C2
pubmed: 31091141
Int J Clin Exp Pathol. 2019 Jul 01;12(7):2474-2484
pubmed: 31934074
Cancer Manag Res. 2020 Apr 09;12:2531-2540
pubmed: 32308490
Int J Mol Sci. 2018 Feb 02;19(2):
pubmed: 29393886
Clin Chim Acta. 2022 Dec 1;537:127-132
pubmed: 36330945
J Control Release. 2019 Oct;311-312:125-137
pubmed: 31476342
Mol Cell Biol. 2001 Sep;21(17):5958-69
pubmed: 11486034
Oncol Lett. 2020 May;19(5):3369-3380
pubmed: 32269609
Medicina (Kaunas). 2019 Jul 17;55(7):
pubmed: 31319555
Semin Oncol Nurs. 2017 May;33(2):172-183
pubmed: 28343836
Drug Dev Res. 2021 Dec;82(8):1131-1143
pubmed: 33818788
J Cell Physiol. 2019 Jul;234(7):11391-11400
pubmed: 30569515
Front Med (Lausanne). 2022 Jun 23;9:759928
pubmed: 35814779
J Cell Physiol. 2019 Aug;234(8):14296-14305
pubmed: 30633364
Oncol Lett. 2020 Sep;20(3):2058-2074
pubmed: 32782524
Clin Exp Pharmacol Physiol. 2022 Jan;49(1):175-187
pubmed: 34546569
Acta Oncol. 2009;48(6):811-21
pubmed: 19513886
Nucleic Acids Res. 2022 Apr 22;50(7):4148-4160
pubmed: 35333330
J Obstet Gynaecol. 2020 Jul;40(5):602-608
pubmed: 31500479
Hum Cell. 2019 Jul;32(3):352-359
pubmed: 30903594
Mol Ther Nucleic Acids. 2020 Mar 6;19:413-420
pubmed: 31896069
EXCLI J. 2023 Jul 12;22:645-669
pubmed: 37636026
Gene. 2019 Jul 15;705:103-108
pubmed: 31029604
Biomed Pharmacother. 2019 Jul;115:108957
pubmed: 31082770
Cancer Sci. 2006 Jul;97(7):563-7
pubmed: 16827794
Annu Rev Biochem. 2012;81:145-66
pubmed: 22663078
Nature. 2013 Mar 21;495(7441):333-8
pubmed: 23446348
Cancer Cell Int. 2021 Jan 14;21(1):54
pubmed: 33446214
Exp Hematol Oncol. 2023 Oct 12;12(1):91
pubmed: 37828589
Curr Mol Med. 2024;24(2):153-166
pubmed: 36627779
Oncol Lett. 2023 Jun 08;26(1):321
pubmed: 37332333
Virology. 2018 Jun;519:1-11
pubmed: 29609071
Bio Protoc. 2018 Mar 20;8(6):
pubmed: 29644261
Mol Cell Biochem. 2021 Nov;476(11):4081-4092
pubmed: 34273059
Am J Transl Res. 2018 Feb 15;10(2):592-604
pubmed: 29511454
Bioengineered. 2022 Apr;13(4):10335-10349
pubmed: 35435110
Curr Oncol. 2022 Oct 25;29(11):7994-8018
pubmed: 36354693
Noncoding RNA. 2020 Sep 23;6(4):
pubmed: 32977531
Front Oncol. 2021 Jan 15;10:590627
pubmed: 33585208
Ann Hematol. 2023 Aug 1;:
pubmed: 37526673
Mol Cancer. 2019 Dec 4;18(1):176
pubmed: 31801551
Signal Transduct Target Ther. 2021 May 21;6(1):185
pubmed: 34016945
Onco Targets Ther. 2020 Feb 28;13:1777-1786
pubmed: 32184614
J Cell Physiol. 2020 Feb;235(2):718-724
pubmed: 31240697
RNA Biol. 2017 Aug 3;14(8):978-984
pubmed: 28402213
J Neurosci Res. 2022 Sep;100(9):1775-1790
pubmed: 35642104
Curr Mol Pharmacol. 2023;16(4):448-464
pubmed: 36043753
Biochim Biophys Acta. 2016 Oct;1859(10):1245-51
pubmed: 27449861
Mol Ther. 2015 May;23(5):812-823
pubmed: 25868399
Dis Markers. 2023 Feb 13;2023:8143581
pubmed: 36815135
Tumour Virus Res. 2022 Jun;13:200238
pubmed: 35460940
Cell. 1991 Feb 8;64(3):607-13
pubmed: 1991322
Cell Death Differ. 2022 Mar;29(3):481-491
pubmed: 35169296
RNA. 2014 Sep;20(9):1476-87
pubmed: 25051970
Mol Med Rep. 2021 Feb;23(2):
pubmed: 33300072
RNA. 2013 Feb;19(2):141-57
pubmed: 23249747
Mol Cancer. 2022 May 5;21(1):108
pubmed: 35513849
J Oncol. 2021 Apr 7;2021:5529486
pubmed: 33880120
J Exp Clin Cancer Res. 2021 Jan 30;40(1):48
pubmed: 33516252
Semin Cancer Biol. 2022 May;80:1-17
pubmed: 31866476
Nat Commun. 2019 May 24;10(1):2300
pubmed: 31127091
Anticancer Drugs. 2022 Oct 1;33(9):850-860
pubmed: 35946546
Aging (Albany NY). 2019 Nov 26;11(22):9982-9999
pubmed: 31772143
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
Lancet. 2014 Feb 8;383(9916):524-32
pubmed: 24192252
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10803-10809
pubmed: 31858548
Front Pharmacol. 2023 Aug 14;14:1224151
pubmed: 37645444
Cell Death Dis. 2019 Dec 12;10(12):950
pubmed: 31831728
Mol Cell. 2017 Apr 6;66(1):9-21.e7
pubmed: 28344080
Cell Rep. 2016 Apr 19;15(3):611-624
pubmed: 27068474
Molecules. 2022 Nov 18;27(22):
pubmed: 36432119
Genes Dev. 2015 Oct 15;29(20):2168-82
pubmed: 26450910
Adv Drug Deliv Rev. 2015 Jan;81:117-27
pubmed: 24859534
Biomed Pharmacother. 2020 Jan;121:109582
pubmed: 31706100
Cancer. 2014 Nov 15;120(22):3446-56
pubmed: 24948110
Aging (Albany NY). 2020 Oct 27;12(20):20139-20151
pubmed: 33109773
Front Cell Dev Biol. 2020 Oct 08;8:568366
pubmed: 33117799
Reprod Sci. 2022 Sep;29(9):2636-2646
pubmed: 35355231
Sci Rep. 2018 Aug 16;8(1):12285
pubmed: 30115981
Cancer Biol Ther. 2020 Oct 2;21(10):972-982
pubmed: 33047994
Nucleic Acids Res. 2012 Apr;40(7):3131-42
pubmed: 22140119
Plant Cell Physiol. 2021 Dec 3;62(10):1572-1588
pubmed: 34255832
J Clin Lab Anal. 2020 Aug;34(8):e23340
pubmed: 32320103
Nat Biotechnol. 2014 May;32(5):453-61
pubmed: 24811520
Biochem Biophys Res Commun. 2018 Jun 22;501(2):428-433
pubmed: 29738762
Cell Biochem Funct. 2021 Dec;39(8):955-969
pubmed: 34708430
Mol Cancer. 2022 Feb 12;21(1):47
pubmed: 35151318
Int J Environ Res Public Health. 2022 Jun 09;19(12):
pubmed: 35742340
Pathol Res Pract. 2021 Nov;227:153618
pubmed: 34649056
Nat Rev Mol Cell Biol. 2021 Feb;22(2):96-118
pubmed: 33353982
Discov Oncol. 2022 May 16;13(1):30
pubmed: 35570248
Mol Ther Nucleic Acids. 2021 Nov 29;27:227-240
pubmed: 34976440
Nat Methods. 2007 Sep;4(9):721-6
pubmed: 17694064
Cell Mol Biol Lett. 2022 Aug 3;27(1):65
pubmed: 35922753
Biochem Genet. 2023 Aug;61(4):1300-1318
pubmed: 36583788
Medicine (Baltimore). 2021 Oct 1;100(39):e27352
pubmed: 34596142
Int J Biol Sci. 2022 Jun 13;18(10):3944-3960
pubmed: 35844799
AJR Am J Roentgenol. 1995 May;164(5):1075-82
pubmed: 7717206
Front Oncol. 2023 Apr 14;13:1149187
pubmed: 37124518
Drug Dev Res. 2022 May;83(3):755-768
pubmed: 34981843
Int J Med Sci. 2020 Aug 29;17(15):2362-2372
pubmed: 32922202
Int J Clin Exp Pathol. 2017 Dec 01;10(12):11924-11931
pubmed: 31966557
Cell. 2022 Jun 23;185(13):2390
pubmed: 35750036
Oncol Rep. 2019 Apr;41(4):2209-2225
pubmed: 30816541
Curr Med Chem. 2024;31(11):1404-1426
pubmed: 36876847
FEBS Lett. 2008 Dec 24;582(30):4113-6
pubmed: 19032954
Cancer Treat Rev. 2004 Apr;30(2):193-204
pubmed: 15023437
Mol Cell. 2013 Sep 26;51(6):792-806
pubmed: 24035497
J Hematol Oncol. 2020 Dec 4;13(1):165
pubmed: 33276800
Neoplasma. 2019 Mar 5;66(2):197-202
pubmed: 30509102